Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation

Background: Allergic asthma is a long-term disorder of the airways resulting from overexpression of immunoglobulin E (IgE) in response to environmental allergens. Patients with poorly controlled asthma are at high risk of exacerbations requiring additional treatment, including hospitalisations. Seve...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: G Norman, R Faria, F Paton, A Llewellyn, D Fox, S Palmer, I Clifton, J Paton, N Woolacott, C McKenna
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: NIHR Journals Library 2013-11-01
Cyfres:Health Technology Assessment
Pynciau:
adults
asthma
children
omalizumab
systematic review
Mynediad Ar-lein:https://doi.org/10.3310/hta17520
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg